BIO-RAD LABORATORIES, INC. Marketable Securities, Unrealized Gain (Loss)
BIO-RAD LABORATORIES, INC. (BIO) reported Marketable Securities, Unrealized Gain (Loss) of $458.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2026-08-04
- BIO-RAD LABORATORIES, INC. marketable securities, unrealized gain (loss) for the quarter ending 2026-06-30 was $458.00M, a 36.96% increase year-over-year.
- BIO-RAD LABORATORIES, INC. marketable securities, unrealized gain (loss) for the quarter ending 2026-03-31 was -$738.20M, a 2421.38% decline year-over-year.
- BIO-RAD LABORATORIES, INC. marketable securities, unrealized gain (loss) for the quarter ending 2025-12-31 was $1.03B.
- BIO-RAD LABORATORIES, INC. marketable securities, unrealized gain (loss) for the quarter ending 2025-09-30 was -$495.30M, a 162.47% decline year-over-year.
- BIO-RAD LABORATORIES, INC. marketable securities, unrealized gain (loss) for fiscal 2025 was $900.40M.
- BIO-RAD LABORATORIES, INC. marketable securities, unrealized gain (loss) for fiscal 2024 was -$2.66B.
- BIO-RAD LABORATORIES, INC. marketable securities, unrealized gain (loss) for fiscal 2023 was -$1.25B.
- BIO-RAD LABORATORIES, INC. marketable securities, unrealized gain (loss) for fiscal 2022 was -$5.19B.
| Period end | Marketable Securities, Unrealized Gain (Loss) 3 month | Marketable Securities, Unrealized Gain (Loss) 3 month as first filed | Marketable Securities, Unrealized Gain (Loss) 6 month | Marketable Securities, Unrealized Gain (Loss) 6 month as first filed | Marketable Securities, Unrealized Gain (Loss) 9 month | Marketable Securities, Unrealized Gain (Loss) 9 month as first filed | Marketable Securities, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $458.00M 10-Q · filed 2026-08-04 | -$280.20M 10-Q · filed 2026-08-04 | $749.30M derived: sum of 3 quarters · filed 2026-08-04 | $254.00M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2026-03-31 | -$738.20M 10-Q · filed 2026-04-30 | $291.30M derived: sum of 2 quarters · filed 2026-04-30 | -$204.00M derived: sum of 3 quarters · filed 2026-04-30 | $130.40M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-12-31 | $1.03B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $534.20M derived: sum of 2 quarters · filed 2026-02-13 | $868.60M derived: sum of 3 quarters · filed 2026-08-04 | $900.40M 10-K · filed 2026-02-13 | |||
| 2025-09-30 | -$495.30M 10-Q · filed 2025-10-29 | -$160.90M derived: sum of 2 quarters · filed 2026-08-04 | -$129.10M 10-Q · filed 2025-10-29 | -$1.11B derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-06-30 | $334.40M 10-Q · filed 2026-08-04 | $366.20M 10-Q · filed 2026-08-04 | -$610.30M derived: sum of 3 quarters · filed 2026-08-04 | $182.60M derived: sum of 4 quarters · filed 2026-08-04 | |||
| 2025-03-31 | $31.80M 10-Q · filed 2026-04-30 | -$944.70M derived: sum of 2 quarters · filed 2026-04-30 | -$151.80M derived: sum of 3 quarters · filed 2026-04-30 | -$3.05B derived: sum of 4 quarters · filed 2026-04-30 | |||
| 2024-12-31 | -$976.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$183.60M derived: sum of 2 quarters · filed 2026-02-13 | -$3.08B derived: sum of 3 quarters · filed 2026-02-13 | -$2.66B 10-K · filed 2026-02-13 | |||
| 2024-09-30 | $792.90M 10-Q · filed 2025-10-29 | $792.89M 10-Q · filed 2024-10-31 | -$2.10B derived: sum of 2 quarters · filed 2025-10-29 | -$1.68B 10-Q · filed 2025-10-29 | -$1.68B 10-Q · filed 2024-10-31 | -$1.36B derived: sum of 4 quarters · filed 2026-02-13 | |
| 2024-06-30 | -$2.90B 10-Q · filed 2025-07-31 | -$2.90B 10-Q · filed 2024-08-02 | -$2.47B 10-Q · filed 2025-07-31 | -$2.47B 10-Q · filed 2024-08-02 | -$2.15B derived: sum of 3 quarters · filed 2026-02-13 | -$2.11B derived: sum of 4 quarters · filed 2026-02-13 | |
| 2024-03-31 | $422.20M 10-Q · filed 2025-05-01 | $422.18M 10-Q · filed 2024-05-08 | $746.44M derived: sum of 2 quarters · filed 2026-02-13 | $782.87M derived: sum of 3 quarters · filed 2026-02-13 | -$812.58M derived: sum of 4 quarters · filed 2026-02-13 | ||
| 2023-12-31 | $324.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $360.67M derived: sum of 2 quarters · filed 2026-02-13 | -$1.23B derived: sum of 3 quarters · filed 2026-02-13 | -$1.25B 10-K · filed 2026-02-13 | |||
| 2023-09-30 | $36.42M 10-Q · filed 2024-10-31 | -$1.56B derived: sum of 2 quarters · filed 2024-10-31 | -$1.58B 10-Q · filed 2024-10-31 | -$597.84M derived: sum of 4 quarters · filed 2025-02-14 | |||
| 2023-06-30 | -$1.60B 10-Q · filed 2024-08-02 | -$1.61B 10-Q · filed 2024-08-02 | -$634.26M derived: sum of 3 quarters · filed 2025-02-14 | -$923.26M derived: sum of 4 quarters · filed 2025-02-14 | |||
| 2023-03-31 | -$17.52M 10-Q · filed 2024-05-08 | $961.18M derived: sum of 2 quarters · filed 2025-02-14 | $672.18M derived: sum of 3 quarters · filed 2025-02-14 | -$666.01M derived: sum of 4 quarters · filed 2025-02-14 | |||
| 2022-12-31 | $978.71M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $689.71M derived: sum of 2 quarters · filed 2025-02-14 | -$648.48M derived: sum of 3 quarters · filed 2025-02-14 | -$5.19B 10-K · filed 2025-02-14 | |||
| 2022-09-30 | -$289.00M 10-Q · filed 2023-10-27 | -$1.63B derived: sum of 2 quarters · filed 2023-10-27 | -$6.17B 10-Q · filed 2023-10-27 | ||||
| 2022-06-30 | -$1.34B 10-Q · filed 2023-08-04 | -$5.88B 10-Q · filed 2023-08-04 | |||||
| 2022-03-31 | -$4.55B 10-Q · filed 2023-05-05 | ||||||
| 2021-09-30 | $4.87B 10-Q · filed 2022-10-28 | $5.90B derived: sum of 2 quarters · filed 2022-10-28 | $7.08B 10-Q · filed 2022-10-28 | ||||
| 2021-06-30 | $1.03B 10-Q · filed 2022-07-29 | $2.21B 10-Q · filed 2022-07-29 | |||||
| 2021-03-31 | $1.18B 10-Q · filed 2022-04-29 | ||||||
| 2020-09-30 | $1.58B 10-Q · filed 2021-10-29 | $2.76B derived: sum of 2 quarters · filed 2021-10-29 | $3.59B 10-Q · filed 2021-10-29 | ||||
| 2020-06-30 | $1.18B 10-Q · filed 2021-07-30 | $2.01B 10-Q · filed 2021-07-30 | |||||
| 2020-03-31 | $827.67M 10-Q · filed 2021-04-30 | ||||||
| 2019-09-30 | -$390.62M 10-Q · filed 2020-10-30 | $325.77M derived: sum of 2 quarters · filed 2020-10-30 | $1.38B 10-Q · filed 2020-10-30 | ||||
| 2019-06-30 | $716.39M 10-Q · filed 2020-07-31 | $1.78B 10-Q · filed 2020-07-31 | |||||
| 2019-03-31 | $1.06B 10-Q · filed 2020-05-08 | ||||||
| 2018-09-30 | $318.01M 10-Q · filed 2019-11-01 | $1.42B 10-Q · filed 2019-11-01 |